Claim/exemption information - Registry number 11845
List of suggested corrective measures
Correct administrative non-compliances.
Correct the disclosure of misleading information regarding fire-fighting measures.
Correct the disclosure of misleading information regarding first aid measures.
Correct the disclosure of misleading information regarding the LD50 values for the ingredients “ethylene glycol monobutyl ether”, “poly(oxy-1,2-ethandiyl), a-(nonylphenyl)-w-hydroxy-” and “alkylalcohol”.
Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
Disclose information on the precautions for firefighters.
Disclose the additional hazard classifications of “Acute Toxicity (Dermal) — Category 4”, “Acute Toxicity (Inhalation) — Category 3”, “Skin Corrosion — Category 1” and “Specific Target Organ Toxicity — Single Exposure — Category 3, narcotic effects (central nervous system)”.
Disclose the applicable common names and synonyms for the ingredients “ethylene glycol monobutyl ether” and “methanol”.
Disclose the calculated product oral ATE value of 629 mg/kg (9% unknown), the calculated product dermal ATE value of 1 449 mg/kg (9% unknown), the calculated product inhalation (vapour) ATE value of 5.1 mg/L (54% unknown) and the calculated product inhalation (dust/mist) ATE value of 6.1 mg/L (80% unknown).
Disclose the hazardous combustion products.
Disclose the information elements concerning the additional hazard and precautionary statements.
Disclose the percent of unknown toxicity of “9%” for the calculated product oral and dermal ATE values, respectively, “54%” for the inhalation (vapours) ATE value and “80%” for the inhalation (dust/must) ATE value.
Disclose the symbol and/or name of the symbol for “Skull and crossbones” on the SDS.
Disclose “ingestion” as an additional likely route of exposure.
Disclose “static discharge” as a condition to avoid.
Disclose “strong acids” as an incompatible material.